Skip to main content
SpringerLink
Log in

Comparison of the effects of acute and chronic beta-blockade on infarct size in the dog after circumflex occlusion

  • Experimental Pharmacology
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Summary

In order to compare the effects of acute and chronic beta-blockade on infact size, the left circumflex coronary artery was occluded for 6 hours in 33 anesthetized dogs. The dogs (18 to 22 kg) were divided in to three groups; group 1 (N=10) served as controls, group 2 received intravenous nadolol (average dose 1.25 mg/kg) just prior to coronary occlusion, and group 3 received oral nadolol (80 mg) twice daily for 16 days prior to coronary occlusion. To ensure equivalent degrees of beta-blockade at the time of occlusion, group 2 and 3 dogs were given incremental doses of intravenous nadolol to abolish the chronotropic response to isoproterenol (2 μ/kg IV). Left ventricular pressure, its first derivative (dP/dt), and heart rate were monitored. The anatomic risk region was determined antemortem by Evan's blue staining while the infarct zone was delineated postmortem by tetrazoleum staining. Compared to Group 1, heart rate was 22% lower in group 2 and 15% lower in group 3 dogs 6 hours after occlusion (p<0.05). There were no differences among groups in peak left ventricular systolic pressure or mean arterial pressure. Infarct size as a function of the area at risk was 68±3% in group 1, 52±7% in group 2, and 44±8% in group 3. A significant difference was found only between groups 3 and 1. The data suggest that chronic beta-blockade provides greater protection against ischemic-induced necrosis than does acute beta-blockade. The greater protective effect of chronic beta-blockade may be due to chronic adaptive changes in either blood flow or metabolism.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Maroko PR, Kjekshus JK, Sobel BE, et al. Factors influencing infarct size following experimental coronary artery occlusion. Circulation 1971; 43:67–82.

    Google Scholar 

  2. Maroko PR, Libby P, Covell JW, et al. Precordial S-T segment elevation mapping: An atraumatic method for assessing alterations in the extent of myocardial ischemic injury. The effects of pharmacologic and hemodynamic interventions. Am J Cardiol 1972; 29:223–230.

    Google Scholar 

  3. Fox K, Welman E, Selwyn A. Myocardial infarction in the dog: Effects of intravenous propranolol. Am J Cardiol 1980; 45:769–774.

    Google Scholar 

  4. Nakazawa M, Katano Y, Imai S, et al. Effects of 1- and d-propranolol on the ischemic myocardial metabolism of the isolated guinea pig heart, as studied by P-NMR. J Cardiovasc Pharmacol 1982; 4:700–704.

    Google Scholar 

  5. Stangeland L, Grong K, Bakken AM, et al. Effects of timolol on adenine nucleotide catabolism in cat hearts with acute regional ischaemia. Cardiovasc Res 1984; 18:327–334.

    Google Scholar 

  6. Rasmussen MM, Reimer K, Kloner RA, et al. Infarct size reduction by propranolol before and after coronary ligation in dogs. Circulation 1977; 55:794–798.

    Google Scholar 

  7. Kloner RA, Fishbein MC, Cotran RS, et al. The effect of propranolol on microvascular injury in acute myocardial ischemia. Circulation 1977; 55:872–880.

    Google Scholar 

  8. Reimer KA, Rasmussen MM, Jennings RB. On the nature of protection by propranolol against myocardial necrosis after temporary coronary occlusion in dogs. Am J Cardiol 1976; 37:520–527.

    Google Scholar 

  9. Reynolds RD, Burmeister WE, Gorczynski RJ, et al. Effects of propranolol on myocardial infarct size with and without coronary artery reperfusion in the dog. Cardiovasc Res 1981; 15:411–420.

    Google Scholar 

  10. Burmeister WE, Reynolds RD, Lee RJ. Limitation of myocardial infarct size by atenolol, nadolol and propranolol in dogs. Eur J Pharmacol 1981; 75:7–10.

    Google Scholar 

  11. Hammerman H, Kloner RA, Briggs LL, et al. Enhancement of salvage of reperfused myocardium by early beta-adrenergic blockade (timolol). J Am Coll Cardiol 1984; 3:1438–1443.

    Google Scholar 

  12. Miura M, Thomas R, Ganz W, et al. The effect of delay in propranolol administration on reduction of myocardial infarct size after experimental coronary artery occlusion in dogs. Circulation 1979; 59:1148–1157.

    Google Scholar 

  13. Vik-Mo H, Maroko PR, Ribeiro LGT. Comparative effects of propranolol, timolol and metoprolol on myocardial infarct size after experimental coronary artery occlusion. J Am Coll Cardiol 1984; 4:735–741.

    Google Scholar 

  14. Gold HK, Leinbach RC, Maroko PR. Propranolol-induced reduction of signs of ischemic injury during acute myocardial infarction. Am J Cardiol 1976; 38:689–695.

    Google Scholar 

  15. Mueller HS, Ayres SM, Religa A, et al. Propranolol in the treatment of acute myocardial infarction. Effect on myocardial oxygen consumption and hemodynamics. Circulation 1974; 49:1078–1087.

    Google Scholar 

  16. Hansteen V, Moinichen E, Lorentsen E, et al. One year's treatment with propranolol after myocardial infarction: Preliminary report of Norwegian multicentre trial. Br Med J 1982; 284:155–160.

    Google Scholar 

  17. The Norwegian Multicenter Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 1981; 304:801–807.

    Google Scholar 

  18. Goldstein S. Propranolol therapy in patients with acute myocardiol infarction: The beta-blocker heart attack trial. Circulation 1983; 67:I153-I157.

    Google Scholar 

  19. Hjalmarson A, Herlitz J, Holmberg S, et al. The Goteborg metoprolol trial: Effects on mortality and morbidity in acute myocardial infarction. Circulation 1983; 67:I126-I132.

    Google Scholar 

  20. Raine AEG, Vaughan Williams EM. Adaption to prolonged beta-blockade of rabbit atrial, Purkinje, and ventricular potentials, and of papillary muscle contraction. Time-course of development of and recovery from adaptation. Circ Res 1981; 48:804–812.

    Google Scholar 

  21. Nayler WG, Yepez CE, Fassold E, et al. Prolonged protective effect of propranolol on hypoxic heart muscle. Am J Cardiol 1978; 42:217–225.

    Google Scholar 

  22. Manning AS, Keogh JM, Shattock MJ, et al. Long-term beta-blockade: Prolonged protective action in the ischemic myocardium. Cardiovasc Res 1981; 15:462–467.

    Google Scholar 

  23. Lee RJ, Evans DB, Baky SH, et al. Pharmacology of nadolol (SQ 11725), a beta-adrenergic antagonist lacking direct myocardial depression. Eur J Pharmacol 1975; 33:371–382.

    Google Scholar 

  24. Wong KK, Dreyfuss J, Shaw JM, et al. A beta-blocking agent (SQ 11725) that is not metabolized extensively by dogs and monkeys. Pharmacologist 1973; 15:245.

    Google Scholar 

  25. Lie JT, Pairolero PC, Holley KE, et al. Macroscopic enzymemapping verification of large, homogeneous, experimental myocardial infarcts of predictable size and location in dogs. J Thorac Cardiovasc Surg 1975; 69:599–605.

    Google Scholar 

  26. Fishbein MC, Meerbaum S, Ritt J. et al. Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. Am Heart J 1981; 101:593–600.

    Google Scholar 

  27. Gillis RA. Role of nervous system in the arrhythmias produced by coronary occlusion in the cat. Am Heart J 1971; 81:677–684.

    Google Scholar 

  28. Karlsberg R, Penkoske PA, Cryer PE, et al. Rapid activation of the sympathetic nervous system following coronary artery occlusion: Relationship to infarct size, site, and haemodynamic impact. Cardiovasc Res 1979; 13:523–531.

    Google Scholar 

  29. Shell WE, Sobel BE. Deleterious effects of increased heart rate on infarct size in the conscious dog. Am J Cardiol 1973; 31:474–479.

    Google Scholar 

  30. Mueller HS, Ayres SM. The role of propranolol in the treatment of acute myocardial infarction. Prog Cardiovasc Dis 1977; 19:405–412.

    Google Scholar 

  31. Haneda T, Lee T, Ganz W. Metabolic effects of propranolol in the ischemic myocardium studied by regional sampling. Circulation 1973; 48:IV-174.

    Google Scholar 

  32. Reimer KA, Jennings RB. Decreasing myocardial energy utilization. In: Wagner GS, ed. Myocardial Infarction: Measurement and Intervention. London: Martinus Nijhoff, 1982:397–414.

    Google Scholar 

  33. Lange R, Nieminen MS, Kloner RA. Failure of pindolol and metoprolol to reduce the size of non-reperfused infarcts in dogs using area at risk techniques. Cardiovasc Res 1984; 18:37–43.

    Google Scholar 

  34. Kudoh Y, Maxwell MP, Hearse DJ, et al. Inability of metoprolol to achieve a sustained limitation in infarct size 24 h after coronary artery embolization in the closed chest dog. J Cardiovasc Pharmacol 1984; 6:1201–1209.

    Google Scholar 

  35. Ribeiro LGT, Cheung W, Maroko PR. Influence of the extent of the zone at risk on the effectiveness of drugs in reducing infarct size. Circulation 1982; 66:181–186.

    Google Scholar 

  36. Chambers DE, Yellon DM, Hearse DJ, Downey JM. Effects of flurbiprofen in altering the size of myocardial infarcts in dogs: Reduction or delay? Am J Cardiol 1983; 51:884–890.

    Google Scholar 

  37. Lowe JE, Reimer KA, Jennings RB. Experimental infarct size as a function of the amount of myocardium at risk. Am J Pathol 1978; 90:363–376.

    Google Scholar 

  38. Jugdutt BI, Hutchkins GM, Bulkley BH, et al. Myocardial infarction in the conscious dog: Three-dimensional mapping of infarct, collateral flow and region at risk. Circulation 1979; 60:1141–1150.

    Google Scholar 

  39. Becker LC, Schuster EH, Jugdutt BI, et al. Relationship between myocardial infarct size and occluded bed size in the dog: Difference between left anterior descending and circumflex coronary artery oclusions. Circulation 1983; 67:549–557.

    Google Scholar 

  40. Mizutani T, Katada Y, Maekawa K, et al. Coronary collateral circulation as an important factor to modify the ischemic injury of the myocardium in coronary ligated dogs. Jpn Heart J 1979; 20:485–493.

    Google Scholar 

  41. Schaper W. Experimental coronary occlusion III. The determinants of collateral flow in acute coronary occlusion. Basic Res Cardiol 1978; 73:584–594.

    Google Scholar 

  42. Reimer KA, Jennings RB, Cobb FR, et al. Animal models for protecting ischemic myocardium: Results of the NHLBI cooperative study. Comparison of unconscious and conscious dogs. Circ Res 1985; 56:651–665.

    Google Scholar 

  43. Miura T, Yellon DM, Hearse DJ, et al. Determinants of infarct size during permanent occlusion of a coronary artery in the closed chest dog. J Am Coll Cardiol 1987; 9:647–654.

    Google Scholar 

  44. Kloner RA, Reimer KA, Jennings RB. Distribution of coronary collateral flow in acute myocardial ischemic injury: Effect of propranolol. Cardiovasc Res 1976; 10:81–90.

    Google Scholar 

  45. Melby K, Bache RJ. Effect of selective beta-adrenergic blockade and stimulation on regional myocardial blood flow following acute coronary artery occlusion in the awake dog. Cardiovasc Res 1980; 14:192–198.

    Google Scholar 

  46. Jones CE, Scheel KW. Reduced coronary collateral resistances after chronic ventricular sympathectomy. Am J Physiol (Heart Circ Physiol) 1980;238(7):H196-H201.

    Google Scholar 

  47. Scheel KW, Jones CE. Reduced resistances of septal artery collateral channels after cardiac sympathectomy. Basic Res Cardiol 1983; 78:373–383.

    Google Scholar 

  48. Dowell RT. Myofibrillar ATPase activity in rat heart after chronic propranolol administration. Am J Physiol (Cell Physiol) 1979; 6(3): C195-C199.

    Google Scholar 

  49. Manning AS, Hearse DJ, Coltart DJ. Effect of chronic beta-blockade on the ischaemic myocardium: A comparative study with five drugs. J Cardiovasc Pharmacol 1982; 4:999–1005.

    Google Scholar 

  50. Campbell CA, Parratt JR, Kane KA, et al. Effects of prolonged administration of oxprenolol on severity of ischaemic arrhythmias, enzyme leakage, infarct size, and intracellular cardiac muscle action potentials. J Cardiovasc Pharmacol 1984; 6:369–377.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Loyola University Medical Center, Maywood, Illinois

    David E. Euler, Patrick J. Hughes & Patrick J. Scanlon

Authors
  1. David E. Euler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Patrick J. Hughes
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Patrick J. Scanlon
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Euler, D.E., Hughes, P.J. & Scanlon, P.J. Comparison of the effects of acute and chronic beta-blockade on infarct size in the dog after circumflex occlusion. Cardiovasc Drug Ther 2, 231–238 (1988). https://doi.org/10.1007/BF00051239

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00051239

Key Words

Search

Navigation